text.skipToContent text.skipToNavigation
Need help? Please contact us
  1. Home
  2. Bone marrow mononuclear cells%3A%3A%3A%3A

You searched for "Bone marrow mononuclear cells%3A%3A%3A%3A"

822 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "Bone marrow mononuclear cells%3A%3A%3A%3A"

1,180 Documents found
  • Transfection Protocol for Mature mDC (C57BL/6) - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of mature mouse dendritic cells (C57BL/6) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for Immature mDC (C57BL/6) - Nucleofector™ I/II/2b Device
    Instructions of use for transfection of immature mouse dendritic cells (C57BL/6) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for Immature mDC (BALB/c) - Nucleofector™ I/II/2b Device
    Instructions of use for transfection of immature mouse dendritic cells (BALB/c) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • PBMC Based T Cell Proliferation Assay
    Protocol instructions
  • Synthego-Lonza Genome Editing of Resting T cells
    Case Study on Genome Editing of Resting T cells
  • Primary and Stem Cell Applications for Diabetes and Obesity Research
    Webinar - PDF Version
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • Efficient Transfection of Cancer Cell Lines Using the 4D-Nucleofector™ System
    Product data sheet showing efficient tranfection of cancer cell lines
  • First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat Cells
    High throughput transfection of siRNA libraries has become a valuable tool in target identifi cation and validation. However, such screenings have so far been constrained to mostly easy-totransfect adherent cell lines. Lonza’s 96-well Shuttle® System, based on the well-established Amaxa® Nucleofector® Technology, extends these approaches to primary and diffi cult-to-transfect cells.
  • Webinar - Hepatocytes in the Drug Development Pipeline
    Overview of how primary hepatocytes are used in drug development
  • Bioscience Solutions - Providing Industry-Leading Research, Discovery and Manufacturing Tools (English)
    Lonza_Brochures_Providing_Industry-Leading_Research_Discovery_and_Manufacturing_Tools_English.pdf
  • Automated Cell Signaling Assays Using Primary HUVECs
    Lonza's Primary HUVECs are an excellent cell type to measure the effects of pharmacologically-important compounds on vial signaling pathways, and they provide increased data relevancy compared to cell lines.
  • 32D Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of 32D cells with the Cell Line Nucleofector™ Kit V
  • TF-1 Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of TF-1 cells with the Cell Line Nucleofector™ Kit T
  • KG-1 Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of KG-1 cells with the Cell Line Nucleofector™ Kit R
  • KG-1a Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of KG-1a cells with the Cell Line Nucleofector™ Kit L
  • FDC-P1 Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of FDC-P1 cells with the Cell Line Nucleofector™ Kit L
  • Advancing Bone Disease Research – Dissociated Rat Calvariae Osteoblasts Display Optimal Mineralization and Are Easily Transfected Using Nucleofection
    The data provided in this white paper show the quality and sensitivity of cryopreserved dissociated rat calvariae osteoblasts for in vitro studies. Furthermore, application of the 4D-Nucleofector™ System for efficient transfection of dissociated osteoblasts represents a significant advantage for investigating bone biology.
  • D1 ORL UVA Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of D1 ORL UVA cells with the Cell Line Nucleofector™ Kit T
  • 3
  • 4(current)
  • 5